galactose has been researched along with Allergic Bronchopulmonary Mycosis in 207 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (3.86) | 29.6817 |
2010's | 163 (78.74) | 24.3611 |
2020's | 36 (17.39) | 2.80 |
Authors | Studies |
---|---|
Alqumber, MAA; Dar, SA; Das, S; Gupta, C; Jain, C; Narang, S; Rai, G; Salhotra, R; Sharma, R; Singh, NP; Singh, PK; Tyagi, A | 1 |
Angelucci, E; Ball, L; Bassetti, M; Dentone, C; Dettori, S; Furfaro, E; Giacobbe, DR; Magnasco, L; Mikulska, M; Pelosi, P; Russo, C; Taramasso, L; Vena, A | 1 |
Afeltra, J; Alvarez, C; Cabeza, MS; Farías, L; Fernández, NB; Garcia-Effron, G; Giuliano, CV; Giusiano, G; Noblega, LM; Ochiuzzi, ME; Santiso, G; Tracogna, F; Vitale, RG | 1 |
Chiou, SS; Cho, SF; Chuang, TM; Du, JS; Gau, YC; Hsiao, CE; Hsiao, HH; Hsiao, SY; Hsieh, CY; Hsu, CM; Ke, YL; Lin, SY; Liu, YC; Lu, PL; Tang, SH; Wang, HC; Yeh, TJ; Yen, CH | 1 |
Acet-Öztürk, NA; Akalın, H; Ali, R; Aydın-Güçlü, Ö; Demirdöğen, E; Ener, B; Görek-Dilektaşlı, A; Kazak, E; Ömer-Topçu, D; Özkalemkaş, F; Özkocaman, V; Pınar, İE; Ursavas, A; Vurat-Acar, K | 1 |
Abastabar, M; Arastehfar, A; Davoodi, L; Ghazanfari, M; Haghani, I; Hedayati, MT; Hoenigl, M; Mayahi, S; Moazeni, M; Pan, W; Yazdani Charati, J | 1 |
Cao, J; Feng, C; He, Q; Li, M; Zhang, M | 1 |
Bellanger, AP; Berceanu, A; Caillet, A; Daguindau, E; Millon, L; Navellou, JC; Rocchi, S; Scherer, E | 1 |
Carmona, EM; Epelbaum, O; Evans, SE; Gabe, LM; Hage, CA; Haydour, Q; Knox, KS; Kolls, JK; Limper, AH; Murad, MH; Wengenack, NL | 1 |
Alkhazraji, S; Alqarihi, A; Gebremariam, T; Gu, Y; Ibrahim, AS; Shaw, KJ; Singh, S | 1 |
Arendrup, MC; Arikan-Akdagli, S; Arsic, V; Barac, A; Cornely, OA; Donnelly, P; Garcia-Vidal, C; Gaustad, P; Herbrecht, R; Klimko, N; Klingspor, L; Lanternier, F; Lass-Flörl, C; Lortholary, O; Maertens, J; Mikulska, M; Munoz, P; Pagano, L; Pulcini, C; Rijnders, B; Sabino, R; Seidel, D; Skiada, A; Styczynski, J; Verissimo, C | 1 |
Sabour, S | 1 |
Einsele, H; Löffler, J; Springer, J; White, PL | 1 |
He, J; Li, X; Peng, H; Qian, H; Xing, B; Xu, M; Yu, Q; Zhang, H | 1 |
Álvarez, AM; Avilés, CL; Claverie, X; Contardo, V; de la Maza, V; Delgado-Araneda, M; Gutierrez, V; Rabello, M; Salgado, C; Santolaya, ME; Tordecilla, J; Torres, JP; Valenzuela, R; Varas, M; Venegas, M; Villarroel, M; Zubieta, M | 1 |
Abastabar, M; Ansari, S; Basharzad, N; Gheisari, M; Haghani, I; Hedayati, MT; Jafarzadeh, J; Mirenayat, MS; Mortezaee, V; Pourabdollah, M; Yazdani Charati, J | 1 |
Chakrabarti, A; Chauhan, A; Jaiswal, N; Pradhan, P; Sharma, M; Singh, M; Singh, S; Verma, N | 1 |
Beigelman-Aubry, C; Bochud, PY; Brunel, AS; Casutt, A; Couchepin, J; Keller, N; Lamoth, F; Lovis, A | 1 |
Geisler, F; Huber, W; Lahmer, T; Rasch, S; Schmid, RM; Spinner, C | 1 |
Boillat-Blanco, N; Glampedakis, E; Lamoth, F; Oddo, M; Pagani, JL | 1 |
Boch, T; Buchheidt, D; Frank, J; Hoenigl, M; Jenks, JD; Mehta, SR; Prattes, J; Spiess, B | 1 |
Buer, J; Kirchhoff, L; Rath, PM; Scharmann, U; Steinmann, J; Verhasselt, HL; Ziegler, K | 1 |
Assous, M; Bergel, M; Chahanian, N; Elinav, H; Haran, A; Korem, M; Temper, V | 1 |
Badali, H; Fakhim, H; Hajiahmadi, S; Mirhendi, H; Nasri, E; Sadeghi, A; Sadeghi, S; Shoaei, P; Vaezi, A; Vakili, B | 1 |
Borman, AM; Brown, P; Dzietczyk, A; Fraser, M; Gough, M; Hedley, M; Johnson, EM; King, J; Linton, CJ; Mann, C; McLachlan, S; Oliver, D; Palmer, MD; Patterson, Z | 1 |
Cao, XJ; Guo, XG; Li, YP; Qin, YS; Xie, LM; Zhang, HL | 1 |
Elbeki, N; Lambiotte, F; Saint-Leger, P; Versyck, M; Zarrougui, W | 1 |
Geisler, F; Heim, M; Herner, A; Hoffmann, D; Huber, W; Kriescher, S; Lahmer, T; Mayer, U; Neuenhahn, M; Rasch, S; Rothe, K; Schmid, RM; Schneider, G; Schneider, J; Spinner, CD | 1 |
Choi, EJ; Choi, SH; Chong, YP; Jung, J; Kim, MJ; Kim, SH; Kim, YS; Lee, JH; Lee, KH; Lee, SO; Lee, YW; Lim, SY; Park, HS | 1 |
Cai, M; Chen, B; Dai, Z; Fang, L; Li, Z; Liang, X; Lin, L; Yao, Y; Yi, H; Zhu, J | 1 |
Hua, L; Huang, L; Zhan, Q; Zhang, Y | 1 |
Chakrabarti, A; Gorsi, U; Jain, A; Jandial, A; Khadwal, A; Lad, DP; Malhotra, P; Muthu, V; Prabhakar, N; Prakash, G; Sharma, R; Singh, C; Suri, V; Varma, S | 1 |
Chi, Y; Du, J; Du, W; Liu, F; Shi, J; Song, Z; Sun, B; Zhang, X | 1 |
Babady, NE; Jani, K; McMillen, T; Morjaria, S | 1 |
Boyer, J; Egger, M; Hoenigl, M; Jenks, JD; Prattes, J; Schulz, E | 1 |
He, Q; Huang, M; Li, H; Li, P; Shi, Y; Su, X; Zhang, F; Zhang, Y; Zhou, W | 1 |
Hope, WW; Kolamunnage-Dona, R; Kovanda, LL; Lee, M; Maertens, J; Neely, M | 1 |
Ansari, S; Denning, DW; Hedayati, MT; Mahdavi Omran, S; Moqarabzadeh, V; Saber, S; Seyedmousavi, S; Taghizadeh-Armaki, M; Verweij, PE; Zarrinfar, H | 1 |
Hope, WW; Hussain, K; Kovanda, LL; Maung, BBW; McCarthy, MW; Petraitiene, R; Petraitis, V; Sekhon, NK; Shaikh, N; Walsh, TJ; Zaw, MH | 1 |
Choi, SH; Chong, YP; Jung, J; Kim, MY; Kim, SH; Kim, YS; Lee, SO; Woo, JH | 1 |
Baccouchi, N; Gargouri, S; Hedhili, S; Jemli, B; Souid, H | 1 |
Duettmann, W; Eigl, S; Heldt, S; Hoenigl, M; Prattes, J; Thornton, C | 1 |
Bhaskaran, A; Bhimji, A; Humar, A; Husain, S; Keshavjee, S; Kumar, D; Kuruvilla, J; Lipton, J; Mazzulli, T; Minden, MD; Pavan, R; Rotstein, C; Schimmer, A; Schuh, A; Singer, LG; Yee, K | 1 |
Kauffman, CA; Miceli, MH | 1 |
Hönigl, M; Lange, C; Salzer, HJF | 1 |
Goldraich, L; Husain, S; Kabbani, D; Ross, H; Rotstein, C | 1 |
Cho, SY; Choi, JH; Choi, JK; Choi, SM; Kim, SH; Lee, DG; Lee, HJ; Lee, JW; Park, SH; Park, YJ; Yoo, JH | 1 |
Chen, L; Chen, Z; Deng, Z; Ma, H; Wang, L; Zhang, Y; Zheng, L; Zhuang, Q | 1 |
Murar, AK; Ojha, UC; Pal, RS; Spalgais, S | 1 |
Bochud, PY; Brunel, AS; Couchepin, J; Jaton, K; Lamoth, F; Meylan, P | 1 |
Candolfi, E; Denis, J; Forouzanfar, F; Herbrecht, R; Kessler, R; Letsher-Bru, V; Sabou, M; Toussaint, E | 1 |
Ader, F; Aguado, JM; Akova, M; Arendrup, MC; Arikan-Akdagli, S; Barnes, RA; Beigelman-Aubry, C; Blot, S; Bouza, E; Brüggemann, RJM; Buchheidt, D; Cadranel, J; Castagnola, E; Chakrabarti, A; Cornely, OA; Cuenca-Estrella, M; Denning, DW; Dimopoulos, G; Fortun, J; Gangneux, JP; Garbino, J; Groll, AH; Heinz, WJ; Herbrecht, R; Heussel, CP; Kibbler, CC; Klimko, N; Kullberg, BJ; Lagrou, K; Lange, C; Lass-Flörl, C; Lehrnbecher, T; Lewis, RE; Löffler, J; Lortholary, O; Maertens, J; Marchetti, O; Meis, JF; Munoz, P; Pagano, L; Ribaud, P; Richardson, M; Roilides, E; Ruhnke, M; Sanguinetti, M; Sheppard, DC; Sinkó, J; Skiada, A; Ullmann, AJ; Vehreschild, MJGT; Verweij, PE; Viscoli, C; Warris, A | 1 |
Bhaskaran, A; Bhimji, A; Humar, A; Husain, S; Keshavjee, S; Kumar, D; Li, Y; Pavan, R; Rotstein, C; Singer, LG | 1 |
Dobias, R; Hamal, P; Holub, C; Jaworska, P; Kanova, M; Lyskova, P; Raska, M; Svobodová, L; Tomaskova, H; Vrba, Z | 1 |
Shen, J; Tong, T; Xu, Y | 1 |
Ashworth, A; Barker, J; Felton, TW; Foden, P; Geraghty, CG; Muldoon, EG; Richardson, MD; Rodriguez-Goncer, I; Thomas, S | 1 |
Datta, K; Feldmesser, M; Francis, J; Marr, KA; Mehta, S; Ostrander, DB; Rock, M | 1 |
Almeida, A; Cerqueira, L; Moura, S | 1 |
Chen, L; Dong, H; Dong, Y; Lei, J; Li, Y; Meng, T; Wang, T; Yang, Q; Zhang, T | 1 |
Cai, LL; Du, XM; Fu, JJ; Gong, DY; Mao, B; Wang, MY; Xiao, W | 1 |
Boch, T; Britsch, S; Buchheidt, D; Hofmann, WK; Jabbour, C; Liebregts, T; Meybohm, P; Michels, JD; Rath, PM; Reinwald, M; Schellongowski, P; Spiess, B; Steinmann, J; Trinkmann, F | 1 |
Chakrabarti, A; Kaur, H; Rudramurthy, SM; Singh, M; Singh, S | 1 |
Chen, G; Feng, J; Guo, Z; Huang, Y; Xie, S; Zhang, L; Zhou, J | 1 |
Hoenigl, M; Jenks, JD; Law, N; Mehta, SR; Reed, SL; Taplitz, R | 1 |
Bellissant, E; Berneau, P; Foulquier, JB; Frérou, A; Lemaitre, F; Petitcollin, A; Saint-Marcoux, F; Tron, C; Verdier, MC | 1 |
Cai, R; Guo, G; He, P; Wang, X; Zhang, M | 1 |
Aslam, S; Hoenigl, M; Jenks, JD; Mehta, SR; Reed, SL; Taplitz, R | 1 |
de Kort, E; Dunbar, A; Guldentops, E; Lagrou, K; Maertens, J; Mercier, T; Reynders, M; Rijnders, B; Schauwvlieghe, A; Verweij, PE | 1 |
Angelucci, E; Borghesi, ML; Cittadini, G; De Carolis, E; Del Bono, V; Drago, E; Furfaro, E; Grazia, CD; Mikulska, M; Pulzato, I; Raiola, AM; Sanguinetti, M; Viscoli, C; Zappulo, E | 1 |
Lass-Flörl, C | 1 |
Dong, H; Jiang, L; Li, J; Liu, L; Song, H; Zhang, S; Zhang, Y | 1 |
Bonten, MJM; Cremer, OL; Haas, PA; Schultz, MJ; van de Groep, K; van de Veerdonk, FL; van der Poll, T; Verboom, DM | 1 |
Cornely, OA; Gräfe, SK; Koehler, FC; Koehler, P; Mellinghoff, SC; Salmanton-García, J; Seidel, D; Steinbach, A | 1 |
Buer, J; Koldehoff, M; Liebregts, T; Pelzer, BW; Rath, PM; Schmidt, D; Seufert, R; Steinmann, J | 1 |
Aram, JA; Chen, X; Jin, J; Liu, Y; Lou, YJ; Meng, H; Pan, S; Patterson, TF; Schwartz, IS; Wu, D; Yan, JL; Zhang, X | 1 |
Hong, SB; Huh, JW; Koh, Y; Lee, SI; Lim, CM; Sung, H | 1 |
Fang, JP; Huang, K; Li, Y; Liao, XY; Qiu, KY; Xu, HG; Zhou, DH | 1 |
Blijlevens, NMA; de Kort, E; Dunbar, A; Guldentops, E; Lagrou, K; Maertens, J; Mercier, T; Reynders, M; Rijnders, B; Schauwvlieghe, A; Verweij, PE; Vonk, AG | 1 |
Desmet, K; Lagrou, K; Maertens, J; Mercier, T; Reséndiz Sharpe, A; Waumans, D | 1 |
Buzina, W; Duettmann, W; Hoenigl, M; Koidl, C; Krause, R; Seeber, K; Strenger, V; Wagner, J; Wölfler, A | 1 |
Barnes, RA; Parr, C; Thornton, C; White, PL | 1 |
Brownback, KR; Pitts, LR; Simpson, SQ | 1 |
Chen, GP; Lin, QC; Lin, X; Wang, JH; Zhang, HY; Zhang, XB | 1 |
Boeckh, M; Fisher, CE; Hohl, TM; Leisenring, W; Pergam, SA; Stevens, AM | 2 |
Bretagne, S; Cabaret, O; Cordonnier, C; Sagaon-Teyssier, L; Schwarzinger, M | 1 |
Clements, RM; Estrada, L; Jon, CK; Mosquera, RA | 1 |
Chang, S; Ding, L; He, H; Li, F; Li, Q; Sun, B; Zhan, Q | 1 |
Bailly, É; Chandenier, J; Desoubeaux, G | 1 |
Anjan, M; Dinand, V; Khanna, S; Oberoi, JK; Sachdeva, A; Wattal, C; Yadav, SP | 1 |
Blot, S; Koulenti, D; Vogelaers, D | 1 |
Buchheidt, D; Buzina, W; Duettmann, W; Hoenigl, K; Hoenigl, M; Koidl, C; Krause, R; Posch, V; Prattes, J; Prueller, F; Raggam, RB; Reinwald, M; Spiess, B; Thornton, CR; Wagner, J; Wölfler, A | 1 |
Bergeron, A; Derouin, F; Menotti, J; Porcher, R; Raffoux, E; Ribaud, P; Sulahian, A; Touratier, S | 1 |
Bo, P; Li, M; Lin, JC; Niu, YY; Xing, YL; Xu, WM; Zhang, CR | 1 |
Chen, SC; De Silva, HD; Halliday, CL; Heng, SC; Kong, DC; Manser, RL; Morrissey, CO; Nation, RL; Seymour, JF; Slavin, MA; Thursky, K | 1 |
Ali, S; Bhargava, R; Fatima, N; Malik, A; Shahid, M | 1 |
Fedorko, DP; Gea-Banacloche, JC; Lionakis, MS; Rose, SR; Vallabhajosyula, S; VanRaden, MJ; Velez, MG | 1 |
Fishman, JA; Prasad, P | 1 |
Barnes, RA; Kimpton, G; White, PL | 1 |
Bouza, E; Guinea, J | 1 |
Ahmad, S; Al-Shaikh, AA; Khan, Z | 1 |
Falcone, M; Giuliano, S; Lucidi, C; Merli, M; Raponi, G; Russo, A; Vena, A; Venditti, M | 1 |
Affolter, K; Halter, J; Hirsch, HH; Jahn, K; Passweg, J; Stolz, D; Tamm, M | 1 |
Boudreault, AA; Courtemanche, C; Danylo, A; Pelletier, R | 1 |
Vehreschild, JJ | 1 |
Buzina, W; Eigl, S; Flick, H; Hoenigl, M; Koidl, C; Krause, R; Palfner, M; Prattes, J; Prüller, F; Raggam, RB; Thornton, CR; Zollner-Schwetz, I | 1 |
Cai, X; Cui, J; Ni, W; Wei, C | 1 |
Furfaro, E; Mikulska, M; Viscoli, C | 1 |
Chen, Y; Gothai, S; Jothy, SL; Sasidharan, S; Sumathy, V; Vijayarathna, S; Yoga Latha, L; Zakaria, Z | 1 |
Avidor, I; Gefen, A; Hakim, F; Kassis, I; Shachor-Meyouhas, Y; Weyl Ben-Arush, M; Zaidman, I | 1 |
Choi, SH; Hong, HL; Jung, J; Kim, SH; Kim, YS; Lee, SO; Woo, JH | 1 |
Li, R; Wan, Z; Wang, S; Yu, J; Zhang, S | 1 |
Bangard, C; Cornely, OA; Frank, K; Grönke, S; Hamprecht, A; Hekmat, K; Liss, B; Maintz, D; Markiefka, B; Michels, G; Vehreschild, JJ; Vehreschild, MJ; Wisplinghoff, H | 1 |
Akay, OM; Aksit, F; Aslan, M; Oz, Y | 1 |
Bagkeris, E; Cotterall, D; Desai, R; Gorton, RL; Kibbler, CC; McHugh, T; White, PL | 1 |
Bayram Akkurt, S; Küpeli, E; Öner Eyüboğlu, F; Sezgin, A; Ulubay, G | 1 |
Alangaden, G; Chander, P; Goggins, MI; Jiang, H; Kizy, AE; Miceli, MH; Ramesh, M; Samuel, L; Sekaran, AK; Thornton, CR | 1 |
Ambasta, A; Carson, J; Church, DL | 1 |
Eigl, S; Flick, H; Hoenigl, M; Koidl, C; Krause, R; Lackner, M; Lass-Flörl, C; Neumeister, P; Palfner, M; Prattes, J; Raggam, RB; Reischies, F; Thornton, CR; Wölfler, A; Wurm, R | 1 |
Almyroudis, NG; Douglas, C; Fox, R; Fredricks, DN; Granwehr, B; Iannone, R; Kauh, E; Kontoyiannis, DP; Maertens, J; Marr, KA; Mullane, KM; Neofytos, D; Railkar, R; Shire, N | 1 |
Biro, S; Bukta, E; Fidler, G; Konya, J; Loeffler, J; Mehes, G; Paholcsek, M; Rejto, L | 1 |
Bacher, JD; Finkelman, MA; Petraitiene, R; Petraitis, V; Walsh, TJ | 1 |
Bellanger, AP; Berceanu, A; Deconinck, E; Grenouillet, F; Grenouillet, FE; Larosa, F; Millon, L | 1 |
Cho, B; Chung, NG; Han, SB; Im, SA; Jeong, DC; Kang, JH; Kim, HK; Kim, SK; Lee, DG; Lee, HS; Lee, JW; Yoon, JS | 1 |
Buchheidt, D; Eigl, S; Flick, H; Hoenigl, M; Krause, R; Neumeister, P; Prattes, J; Raggam, RB; Reinwald, M; Reischies, F; Spiess, B; Thornton, CR; Zollner-Schwetz, I | 1 |
Aarabi, N; Goudarzipour, K; Hassanzad, M; Khalilzadeh, S; Mahdaviani, A; Mohammadi, S; Pourabdollah, M; Sigari, N | 1 |
Bel, EH; de Kruif, MD; Gerritsen, MG; Jonkers, RE; van Haren, EH | 1 |
Akalin, H; Ali, R; Ener, B; Gunaldi, M; Kazak, E; Okuturlar, Y; Ozcelik, T; Ozkalemkas, F; Ozkan, HA; Ozkocaman, V; Serin, SO | 1 |
Gilliam, BL; Kleinberg, ME; Ryscavage, PA; Taremi, M; Wang, EW | 1 |
Boch, T; Buchheidt, D; Hofmann, WK; Miethke, T; Reinwald, M; Spiess, B | 1 |
Cho, SY; Chung, DR; Ha, YE; Kang, CI; Kang, ES; Kim, K; Ko, JH; Lee, JY; Peck, KR; Song, JH | 1 |
Aydoğdu, M; Civil, F; Dizbay, M; Gürsel, G; Hızel, K; Kalkancı, A; Özger, S | 1 |
De Rueda, B; Delgado, MP; Domingo, MP; Gálvez, EM; Pardo, J; Revillo, MJ; Rezusta, A; Roc, L; Vidal-García, M | 1 |
Boch, T; Buchheidt, D; Groll, AH; Hofmann, WK; Lehrnbecher, T; Reinwald, M; Spiess, B | 1 |
Barnes, RA; Bretagne, S; Donnelly, JP; Herrera, M; Kirkpatrick, WR; Loeffler, J; Melchers, W; Najvar, LK; Patterson, TF; White, PL; Wickes, B; Wiederhold, NP | 1 |
Hope, WW; Katragkou, A; Kovanda, LL; Moradi, PW; Petraitiene, R; Petraitis, V; Strauss, GE; Walsh, TJ | 1 |
Brossas, JY; Brun, S; Datry, A; Fekkar, A; Gauthier, L; Gay, F; Imbert, S; Joly, I; Mazier, D; Touafek, F; Uzunov, M | 1 |
Chen, SC; Chen, YY; Huang, WC; Sun, KS; Tsai, CF | 1 |
Dresselaers, T; Govaerts, K; Hillen, A; Himmelreich, U; Lagrou, K; Maertens, J; Poelmans, J; Vande Velde, G; Vanherp, L | 1 |
Aguado, JM; Benito, D; Cabanillas, JJ; Castaño, F; Fernández-Ruiz, M; Fortún, J; García-Luján, R; Garcia-Rodríguez, J; Gomez Garcia de la Pedrosa, E; Lazaro, F; Martín-Dávila, P; Moreno, S; Quiles, I; Silva, JT; Venanzi, E | 1 |
Bonate, P; Desai, A; Hope, WW; Kovanda, LL; Petraitiene, R; Petraitis, V; Walsh, TJ | 1 |
Chan, JF; Chan, SM; Cheng, VC; Hung, IF; Lau, SK; Leung, SS; Pang, CM; So, SY; To, KK; Wong, SC; Woo, PC; Xiao, C; Yuen, KY | 1 |
Beitz, A; Huber, W; Lahmer, T; Rasch, S; Schmid, RM; Schnappauf, C | 1 |
Li, R; Que, C; Wan, Z; Wang, S; Yu, J; Zhang, S | 1 |
Douglas, C; Iannone, R; Paderu, P; Perlin, DS; Railkar, R; Shire, N; Zhao, Y | 1 |
Held, J; Huber, W; Lahmer, T; Neuenhahn, M; Rasch, S; Schmid, RM | 1 |
Gao, Y; Yu, Y; Zhu, C | 1 |
Einsele, H; Eyrich, M; Hafner, J; Heussel, CP; Loeffler, J; Löffler, C; Mengoli, C; Michel, D; Schlegel, PG; Springer, J; Ullmann, AJ; White, PL; Wiegering, V; Wirth, C; Wölfl, M | 1 |
Akinci, AB; Avcu, G; Aydinok, Y; Bal, ZS; Karapinar, DY; Metin, DY; Polat, SH; Sahin, A; Sivis, ZO; Vardar, F | 1 |
Gołaś, M; Mierzwińska-Nastalska, E; Netsvyetayeva, I; Piskorska, K; Przybyłowska, D; Sikora, M; Swoboda-Kopeć, E | 1 |
Blennow, O; Duarte, RF; Maertens, JA; Muñoz, P | 1 |
Atalay, MA; Demir, K; Demiraslan, H; Doganay, M; Eren, E; Kaynar, L; Koc, AN | 1 |
Brecht, M; Cornely, OA; Groll, AH; Heussel, CP; Silling, G; Vehreschild, JJ; Vehreschild, MJGT; Würthwein, G | 1 |
Lü, PH; Shi, Y; Wen, YT; Zhao, BL | 1 |
Desai, R; Hoffman, JA; Ross, LA | 1 |
Akashi, K; Eriguchi, Y; Harada, M; Kadowaki, M; Maehara, Y; Miyake, N; Nagasaki, Y; Shimono, N; Uchida, Y | 1 |
Jiang, ZF; Zhang, XY; Zhao, SY | 1 |
DU, W; Liu, DW; Liu, Y; Long, Y; Rui, X; Shi, Y; Wang, XT; Zhou, X | 1 |
Bocanegra, R; Kirkpatrick, WR; Najvar, LK; Patterson, TF; Thornton, CR; Wiederhold, NP | 2 |
Aoki, T; Kimura, SI; Matsue, K; Odawara, J; Takeuchi, M; Yamakura, M | 1 |
Lagrou, K; Maertens, J; Maertens, V; Meers, S; Meersseman, P; Meersseman, W; Theunissen, K; Van Eldere, J; Verbeken, E; Verhoef, G | 1 |
Baixench, MT; Dupouy-Camet, J; Lebuisson, A; Paugam, A | 1 |
Chan, DS; Ding, Y; Hsu, LY; Khoo, KL; Koh, LP; Phua, J; Tambyah, PA | 1 |
Rijnders, BJ; Slobbe, L | 1 |
Donnelly, JP; Leeflang, MM | 1 |
Danpornprasert, P; Foongladda, S; Tscheikuna, J | 1 |
Camargo, JJ; Camargo, SM; de Oliveira Costa, CD; Pasqualotto, AC; Sánchez, LB; Schio, SM; Severo, LC; Sukiennik, TC; Xavier, MO | 1 |
Aghamolla, T; Bacher, J; Hope, WW; Petraitiene, R; Petraitis, V; Walsh, TJ | 1 |
Acosta, J; Catalan, M; Cuetara, MS; del Palacio, A; del Palacio-Peréz-Medel, A; Lora, D; Montejo, JC; Moragues, MD; Ponton, J | 1 |
Choi, CM; Choi, SH; Hong, SB; Kim, MN; Kim, SH; Kim, YS; Koh, Y; Lee, SO; Oh, YM; Park, SY; Shim, TS; Sung, H; Woo, JH | 1 |
Cadrin-Tourigny, J; Carignan, S; Filion, C; Labbé, AC; Laverdière, M; Luong, ML; Pépin, J; Roy, J; Sheppard, DC | 1 |
Chang, S; Ding, L; He, H; Li, F; Zhan, Q | 1 |
Aydoğan, S; Kalkancı, A; Kuştimur, S | 1 |
Clancy, CJ; Cline, C; Jantz, MA; Kulkarni, V; Leather, H; Nguyen, MH; Wheat, LJ; Wingard, JR | 1 |
Ayadi, A; Dumon, H; Elloumi, M; Hadrich, I; Makni, F; Mary, C; Ranque, S | 1 |
Bellanger, AP; Deconinck, E; Gbaguidi-Haore, H; Grenouillet, F; Henon, T; Legrand, F; Loewert, S; Millon, L; Rohrlich, P; Scherer, E | 1 |
Chai, LY; Hsu, LY | 1 |
Jurado, M; Sainz, J; Segura-Catena, J | 1 |
Cheah, FK; Chlebicka, NL; Goh, YT; Kurup, A; Lin, RT; Low, JG; Tan, BH; Wong, GC | 1 |
Clancy, CJ; Crespo, M; Grantham, KJ; Kleiboeker, SB; Kwak, EJ; Luong, ML; Nguyen, MH; Pakstis, D; Pilewski, J; Reddy, SK; Shields, RK; Silveira, FP; Toyoda, Y; Vadnerkar, A; Walsh, TJ; Wissel, MC | 1 |
Choi, JH; Choi, SM; Eom, KS; Kim, HJ; Kim, SH; Kwon, JC; Lee, DG; Lee, S; Min, WS; Park, SH; Yoo, JH | 1 |
Ko, WC; Lee, HC; Lo, HJ; Wu, CJ | 1 |
Bretagne, S; Coignard, B; de Monbrison, F; Dromer, F; Gangneux, JP; Le Strat, Y; Lebeau, B; Lortholary, O; Sitbon, K | 1 |
Antinori, S; Corbellino, M; Ferraris, L; Galimberti, L; Giuliani, G; Maruzzi, M; Milazzo, L; Ridolfo, AL | 1 |
Patterson, TF | 1 |
Anaissie, E; Barlogie, B; Grazziutti, M; Kumar, NS; Nouér, SA; Nucci, M | 1 |
Falcone, M; Mancini, C; Morelli, A; Russo, A; Vena, A; Venditti, C; Venditti, M | 1 |
Ben Abdeljelil, J; Ben Saïd, M; Ben Youssef, Y; Bouabid, Z; Fathallah, A; Gheith, S; Khammari, I; Khlif, A; Saghrouni, F | 1 |
Buresova, L; Hrncirova, K; Kocmanova, I; Lengerova, M; Mayer, J; Racil, Z; Rolencova, M; Skrickova, J; Toskova, M; Volfova, P; Weinbergerova, B; Winterova, J | 1 |
Jones, B; Kirkpatrick, WR; Lappin, DF; McCulloch, E; Patterson, TF; Rajendran, R; Ramage, G; Shrief, R; Warn, P; Williams, C | 1 |
Amouri, I; Ayadi, A; Bellaaj, H; Cheikhrouhou, F; Elloumi, M; Hadrich, I; Makni, F; Neji, S; Sellami, H; Trabelsi, H | 1 |
Bergeron, A; Bouges-Michel, C; Brethon, B; Chagnon, K; Cornet, M; Derouin, F; Isnard, F; Lacroix, C; Latgé, JP; Menotti, J; Poirot, JL; Porcher, R; Raffoux, E; Ribaud, P; Sulahian, A; Tazi, A; Touratier, S; Vekhoff, A | 1 |
Hrncirova, K; Kirkpatrick, WR; Kocmanova, I; Lengerova, M; Mayer, J; Najvar, LK; Patterson, TF; Pospisilova, S; Racil, Z; Wiederhold, NP | 1 |
D'Haese, J; De Vlieger, G; Lagrou, K; Lammertijn, L; Maertens, J; Meersseman, P; Meersseman, W; Schoemans, H; Theunissen, K; Vermeulen, E | 1 |
Andreolla, HF; Aquino, VR; de-Paris, F; Denning, DW; Goldani, LZ; Nagel, F; Pasqualotto, AC; Xavier, MO | 1 |
Alborzi, A; Badiee, P; Haddadi, P; Karimi, M; Mardaneh, J; Moieni, M; Pourabbas, B | 1 |
Chai, LY; Donnelly, PJ; Herbrecht, R; Johnson, EM; Khin, LW; Kullberg, BJ; Lortholary, O; Maertens, J; Netea, MG; Schlamm, HT; Teerenstra, S; Troke, PF; Vonk, AG | 1 |
Baghaei, P; Droudinia, A; Javanmard, P; Mansouri, D; Marjani, M; Najafizadeh, K; Sarrafzadeh, SA; Soraghi, A; Tabarsi, P; Zandian, P | 1 |
Al-Nakeeb, Z; Arendrup, MC; Cuenca-Estrella, M; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Jeans, AR; Lass-Flörl, C; Majithiya, JB; Warn, PA | 1 |
Ding, L; He, H; Li, F; Sun, B; Zhan, Q | 1 |
Chen, L; Chen, P; Fan, X; Huang, Z; Li, J; Tang, L; Zhao, S; Zhao, Z; Zou, M | 1 |
de Jongste, JC; de Mol, M; de Vries, AH; Hop, WC; Janssens, HM; Merkus, PJ; van Westreenen, M; Warris, A | 1 |
Avni, T; Leibovici, L; Levy, I; Paul, M; Sprecher, H; Yahav, D | 1 |
Atalay, MA; Koç, N; Sav, H; Unal, E | 1 |
Li, R; Mu, X; Yu, J | 1 |
Bansal, D; Chakrabarti, A; Jha, AK; Marwaha, RK; Shivaprakash, MR; Trehan, A | 1 |
16 review(s) available for galactose and Allergic Bronchopulmonary Mycosis
Article | Year |
---|---|
Comparative accuracy of 1,3 beta-D glucan and galactomannan for diagnosis of invasive fungal infections in pediatric patients: a systematic review with meta-analysis.
Topics: beta-Glucans; Child; Clinical Laboratory Techniques; Galactose; Humans; Invasive Fungal Infections; Invasive Pulmonary Aspergillosis; Mannans; Pediatrics; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2021 |
[Aspergillus in airway material : Ignore or treat?]
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Bronchoalveolar Lavage Fluid; Galactose; Humans; Immunoglobulin G; Invasive Pulmonary Aspergillosis; Lung; Lung Diseases, Fungal; Mannans; Respiratory System; Virulence | 2017 |
Serum galactomannan for diagnosing invasive aspergillosis in pediatric patients: A meta-analysis.
Topics: Adolescent; Adult; Aspergillosis; Biomarkers; Child; Child, Preschool; Databases, Factual; Diagnostic Tests, Routine; Galactose; Humans; Infant; Infant, Newborn; Invasive Pulmonary Aspergillosis; Mannans; Meta-Analysis as Topic; Probability; ROC Curve; Sensitivity and Specificity; Young Adult | 2018 |
Invasive pulmonary aspergillosis: current diagnostic methodologies and a new molecular approach.
Topics: Aspergillus fumigatus; beta-Glucans; Galactose; Glycoproteins; Humans; Invasive Pulmonary Aspergillosis; Mannans | 2018 |
The performance of galactomannan in combination with 1,3-β-D-glucan or aspergillus-lateral flow device for the diagnosis of invasive aspergillosis: Evidences from 13 studies.
Topics: Antigens, Fungal; Aspergillus; beta-Glucans; Diagnostic Tests, Routine; Galactose; Humans; Immunoassay; Invasive Pulmonary Aspergillosis; Mannans; Microbiological Techniques; Odds Ratio; Sensitivity and Specificity | 2019 |
How to make a fast diagnosis in invasive aspergillosis.
Topics: Aspergillus; Biopsy; Bronchoalveolar Lavage Fluid; Diagnostic Tests, Routine; Galactose; Histocytochemistry; Humans; Invasive Pulmonary Aspergillosis; Lung; Mannans; Microbiological Techniques; Microscopy; Polymerase Chain Reaction | 2019 |
Baseline predictors influencing the prognosis of invasive aspergillosis in adults.
Topics: Adult; Antifungal Agents; Aspergillus; Galactose; Graft vs Host Disease; Humans; Immunosuppression Therapy; Invasive Pulmonary Aspergillosis; Mannans; Neutropenia; Prognosis; Retrospective Studies; Risk Factors; Treatment Failure; Treatment Outcome | 2019 |
Diagnosis of invasive pulmonary aspergillosis: updates and recommendations.
Topics: Antibodies, Fungal; Antigens, Fungal; Aspergillus; beta-Glucans; Biomarkers; Biopsy; Diagnostic Imaging; DNA, Fungal; Early Diagnosis; Europe; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Mannans; Practice Guidelines as Topic; Predictive Value of Tests; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Current challenges in the microbiological diagnosis of invasive aspergillosis.
Topics: Aspergillus; Body Fluids; Chromatography, Affinity; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Microbiological Techniques; Molecular Diagnostic Techniques; Sensitivity and Specificity | 2014 |
Non-cultural methods for the diagnosis of invasive fungal disease.
Topics: Antigens, Fungal; beta-Glucans; Candidiasis, Invasive; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Microbiological Techniques; Polymerase Chain Reaction | 2015 |
Our 2015 approach to invasive pulmonary aspergillosis.
Topics: Antifungal Agents; Aspergillus; Bronchoalveolar Lavage Fluid; Chemoprevention; Fever of Unknown Origin; France; Galactose; Hospitals, University; Humans; Invasive Pulmonary Aspergillosis; Mannans; Microbial Sensitivity Tests; Radiography, Thoracic; Tomography, X-Ray Computed; Triazoles | 2015 |
The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients.
Topics: Biomarkers; Early Diagnosis; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Mycological Typing Techniques; Polymerase Chain Reaction | 2015 |
Biomarker-based diagnostic work-up of invasive pulmonary aspergillosis in immunocompromised paediatric patients--is Aspergillus PCR appropriate?
Topics: Adolescent; Adult; Aspergillus; beta-Glucans; Biomarkers; Bronchoalveolar Lavage Fluid; Child; Child, Preschool; DNA, Fungal; Female; Galactose; Humans; Immunocompromised Host; Infant; Invasive Pulmonary Aspergillosis; Mannans; Polymerase Chain Reaction; Predictive Value of Tests; Proteoglycans; Young Adult | 2016 |
Recent advances in invasive pulmonary aspergillosis.
Topics: Antifungal Agents; Biomarkers; Galactose; Humans; Invasive Pulmonary Aspergillosis; Lectins, C-Type; Mannans; Membrane Proteins; Nerve Tissue Proteins; Polymorphism, Genetic; Pyrimidines; Toll-Like Receptor 4; Triazoles; Voriconazole | 2011 |
Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis.
Topics: Bronchoalveolar Lavage Fluid; Case-Control Studies; Diagnostic Tests, Routine; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Odds Ratio; Predictive Value of Tests; Probability; Reproducibility of Results; ROC Curve; Sensitivity and Specificity | 2012 |
Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review.
Topics: Bronchoalveolar Lavage Fluid; Case-Control Studies; Clinical Laboratory Techniques; Galactose; Humans; Immunoassay; Invasive Pulmonary Aspergillosis; Mannans; Mycology; Polymerase Chain Reaction; Prospective Studies; Retrospective Studies; Sensitivity and Specificity | 2012 |
8 trial(s) available for galactose and Allergic Bronchopulmonary Mycosis
Article | Year |
---|---|
Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response.
Topics: Adult; Aged; Biomarkers; Drug Monitoring; Female; Galactose; Humans; Invasive Fungal Infections; Invasive Pulmonary Aspergillosis; Logistic Models; Male; Mannans; Middle Aged; Nitriles; Proportional Hazards Models; Pyridines; Survival Analysis; Treatment Outcome; Triazoles | 2017 |
Sputum signatures for invasive pulmonary aspergillosis in patients with underlying respiratory diseases (SPARED): study protocol for a prospective diagnostic trial.
Topics: Biomarkers; Bronchoalveolar Lavage Fluid; Bronchoscopy; Clinical Protocols; Early Diagnosis; Galactose; Humans; Intensive Care Units; Invasive Pulmonary Aspergillosis; Length of Stay; Mannans; Prospective Studies; Respiration Disorders; ROC Curve; Sensitivity and Specificity; Sputum; Survival Analysis | 2018 |
Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 data.
Topics: Adult; Anidulafungin; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Karnofsky Performance Status; Lung; Male; Mannans; Middle Aged; Platelet Count; Prospective Studies; Tomography, X-Ray Computed; Voriconazole | 2019 |
Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antigens, Fungal; Aspergillus; beta-Glucans; Bronchoalveolar Lavage Fluid; Cell Culture Techniques; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Point-of-Care Systems; Prospective Studies; Proteoglycans; Respiratory Tract Diseases; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2014 |
Diagnostic value of the serum galactomannan and (1, 3)-β-D-glucan assays for invasive pulmonary aspergillosis in non-neutropenic patients.
Topics: Adult; Aged; Aged, 80 and over; beta-Glucans; Biomarkers; China; Early Diagnosis; Female; Galactose; Humans; Intensive Care Units; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Neutropenia; Proteoglycans; Sensitivity and Specificity; Young Adult | 2014 |
Serum galactomannan screening for diagnosis of invasive pulmonary aspergillosis in children after stem cell transplantation or with high-risk leukemia.
Topics: Adolescent; Adult; Allografts; Autografts; Child; Child, Preschool; Female; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Invasive Pulmonary Aspergillosis; Leukemia; Male; Mannans; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam | 2015 |
Pharmacodynamics of isavuconazole in experimental invasive pulmonary aspergillosis: implications for clinical breakpoints.
Topics: Animals; Antifungal Agents; Aspergillus; Disease Models, Animal; Drug Monitoring; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Microbial Sensitivity Tests; Models, Theoretical; Monte Carlo Method; Nitriles; Pyridines; Rabbits; Triazoles | 2016 |
Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Fever; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Prospective Studies; Pyrimidines; Radiography, Thoracic; Risk Factors; Singapore; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2011 |
183 other study(ies) available for galactose and Allergic Bronchopulmonary Mycosis
Article | Year |
---|---|
Utility of serum Galactomannan in diagnosing COVID-19 patients with suspected IPA: an observational study in resource limited settings.
Topics: Adult; Aged; COVID-19; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Humans; Interleukin-6; Invasive Pulmonary Aspergillosis; Length of Stay; Male; Mannans; Middle Aged; Pilot Projects; Prospective Studies; SARS-CoV-2; Sex Factors | 2022 |
Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients.
Topics: Aspergillus; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; COVID-19; Critical Illness; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Polymerase Chain Reaction; Sensitivity and Specificity | 2022 |
Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina.
Topics: Animals; Argentina; Aspergillus; COVID-19; Critical Illness; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Prospective Studies; Pulmonary Aspergillosis; Sensitivity and Specificity | 2022 |
Comparison of a novel lateral-flow device to galactomannan assay at different time periods for detections of invasive aspergillosis.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus; Galactose; Humans; Invasive Fungal Infections; Invasive Pulmonary Aspergillosis; Mannans; Sensitivity and Specificity; Steroids | 2022 |
Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy.
Topics: Bronchoalveolar Lavage Fluid; Bronchoscopy; Galactose; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Mannans; Mycoses; Prognosis; Retrospective Studies; Sensitivity and Specificity | 2022 |
Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis.
Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; COVID-19; COVID-19 Testing; Galactose; Humans; Immunoenzyme Techniques; Invasive Pulmonary Aspergillosis; Mannans; Pulmonary Aspergillosis; Sensitivity and Specificity | 2022 |
Diagnosis values of Dectin-1 and IL-17 levels in plasma for invasive pulmonary aspergillosis in bronchiectasis.
Topics: Bronchiectasis; Bronchoalveolar Lavage Fluid; Galactose; Humans; Interleukin-17; Invasive Pulmonary Aspergillosis; Mannans; Retrospective Studies; Sensitivity and Specificity | 2022 |
Refractory invasive pulmonary aspergillosis due to Aspergillus flavus detected with the combination of two in-house Aspergillus qPCR.
Topics: Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Mannans | 2023 |
Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary and Critical Care Practice. An Official American Thoracic Society Clinical Practice Guideline.
Topics: Candidiasis, Invasive; Critical Care; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Polymerase Chain Reaction; Serology; Societies, Medical; United States | 2019 |
Galactomannan Is a Biomarker of Fosmanogepix (APX001) Efficacy in Treating Experimental Invasive Pulmonary Aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biomarkers; Galactose; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lung; Male; Mannans; Mice; Microbial Sensitivity Tests; Triazoles | 2019 |
Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM survey.
Topics: Antifungal Agents; Antigens, Fungal; Aspergillus; Biomarkers; Bronchoalveolar Lavage Fluid; Cross-Sectional Studies; Disease Management; Duration of Therapy; Europe; Galactose; Hematologic Neoplasms; Humans; Internationality; Invasive Pulmonary Aspergillosis; Mannans; Positron-Emission Tomography; Surveys and Questionnaires | 2020 |
Serum galactomannan antigen test combined with chest computed tomography for invasive pulmonary aspergillosis in pediatric patients after hematopoietic stem cell transplantation; Methodological issues on early diagnostic value.
Topics: Child; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Mannans; Tomography | 2020 |
The screening of blood by Aspergillus PCR and galactomannan ELISA precedes BAL detection in patients with proven and probable IA.
Topics: Adolescent; Adult; Aged; Aspergillus; Bronchoalveolar Lavage Fluid; Early Diagnosis; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Leukemia; Male; Mannans; Middle Aged; Polymerase Chain Reaction; Young Adult | 2020 |
Potential value of serum Aspergillus IgG antibody detection in the diagnosis of invasive and chronic pulmonary aspergillosis in non-agranulocytic patients.
Topics: Aged; Antibodies, Fungal; Aspergillus; Biomarkers; Chronic Disease; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Humans; Immunoglobulin G; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; ROC Curve; Sensitivity and Specificity | 2020 |
Usefulness of serum galactomannan in initiating and modifying antifungal therapy in children with cancer and persistent high-risk febrile neutropenia.
Topics: Antifungal Agents; Aspergillosis; Case-Control Studies; Chemotherapy-Induced Febrile Neutropenia; Child; Female; Galactose; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Invasive Pulmonary Aspergillosis; Male; Mannans; Neoplasms | 2020 |
Galactomannan detection in bronchoalveolar lavage fluids: A diagnostic approach for fungus ball in patients with pulmonary tuberculosis?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspergillus; Bronchoalveolar Lavage Fluid; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Iran; Male; Mannans; Middle Aged; Predictive Value of Tests; ROC Curve; Tomography, X-Ray Computed; Tuberculosis, Pulmonary; Young Adult | 2020 |
High prevalence of peribronchial focal lesions of airway invasive aspergillosis in hematological cancer patients with prolonged neutropenia.
Topics: Adult; Aged; Biomarkers; Bronchial Diseases; Bronchoscopy; Female; Galactose; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Neutropenia; Prevalence; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2020 |
Invasive pulmonary aspergillosis in severe coronavirus disease 2019 pneumonia.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Betacoronavirus; Biomarkers; Bronchoalveolar Lavage Fluid; C-Reactive Protein; Coronavirus Infections; COVID-19; Disease Progression; Fatal Outcome; Galactose; Humans; Interleukin-6; Invasive Pulmonary Aspergillosis; Male; Mannans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe Acute Respiratory Syndrome | 2020 |
Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients.
Topics: Aged; Antibodies, Monoclonal, Humanized; Cohort Studies; Coinfection; COVID-19; Critical Illness; Galactose; Humans; Incidence; Intensive Care Units; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Pandemics; Respiration, Artificial; Switzerland | 2020 |
Performance of the Bronchoalveolar Lavage Fluid Aspergillus Galactomannan Lateral Flow Assay With Cube Reader for Diagnosis of Invasive Pulmonary Aspergillosis: A Multicenter Cohort Study.
Topics: Antigens, Fungal; Aspergillus; Bronchoalveolar Lavage Fluid; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Retrospective Studies; Sensitivity and Specificity | 2021 |
Evaluation of two lateral flow assays in BAL fluids for the detection of invasive pulmonary aspergillosis: A retrospective two-centre study.
Topics: Algorithms; Antigens, Fungal; Aspergillus; Bronchoalveolar Lavage Fluid; Chromatography, Affinity; Female; Galactose; Humans; Immunoassay; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Retrospective Studies; Sensitivity and Specificity | 2020 |
False-positive galactomannan antigen testing in pulmonary nocardiosis.
Topics: Aged; Antigens, Fungal; Aspergillus; Bronchoalveolar Lavage Fluid; Enzyme-Linked Immunosorbent Assay; False Positive Reactions; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Nocardia Infections; Sensitivity and Specificity | 2021 |
Fatal Invasive Pulmonary Aspergillosis in COVID-19 Patient with Acute Myeloid Leukemia in Iran.
Topics: Adult; COVID-19; Fatal Outcome; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Iran; Leukemia, Myeloid, Acute; Mannans; SARS-CoV-2 | 2020 |
COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Fungal; Aspergillus fumigatus; beta-Glucans; Bronchoalveolar Lavage Fluid; COVID-19; Critical Illness; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Proteoglycans; Real-Time Polymerase Chain Reaction; SARS-CoV-2; United Kingdom | 2020 |
Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis.
Topics: Area Under Curve; Bronchoalveolar Lavage Fluid; False Negative Reactions; Galactose; Humans; Invasive Fungal Infections; Invasive Pulmonary Aspergillosis; Likelihood Functions; Mannans; Probability; Reproducibility of Results; ROC Curve; Sensitivity and Specificity | 2020 |
Invasive pulmonary aspergillosis in COVID-19 critically ill patients: Results of a French monocentric cohort.
Topics: Adult; Aged; Aged, 80 and over; beta-Glucans; Biomarkers; Comorbidity; COVID-19; Critical Illness; Female; France; Galactose; Hospitals, General; Humans; Immunocompromised Host; Intensive Care Units; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Opportunistic Infections; Respiration, Artificial; Respiratory Distress Syndrome; Retrospective Studies; Risk Factors | 2021 |
Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study.
Topics: Adult; Aged; Aged, 80 and over; Bronchoalveolar Lavage Fluid; COVID-19; Critical Illness; Female; Galactose; Humans; Intensive Care Units; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Pneumonia, Viral; Prospective Studies; Respiration, Artificial; SARS-CoV-2; Superinfection | 2021 |
Diagnostic yield of a bronchoalveolar lavage fluid galactomannan assay in patients with negative serum galactomannan results suspected to have invasive pulmonary aspergillosis.
Topics: Bronchoalveolar Lavage Fluid; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Negative Results; Republic of Korea; Retrospective Studies; Sensitivity and Specificity; Tertiary Care Centers | 2021 |
Comparing the diagnostic value of bronchoalveolar lavage fluid galactomannan, serum galactomannanan, and serum 1,3-β-d-glucan in non-neutropenic respiratory disease patients with invasive pulmonary aspergillosis.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bronchoalveolar Lavage Fluid; Female; Galactose; Glucans; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged | 2021 |
Diagnostic value of galactomannan test in non-immunocompromised critically ill patients with influenza-associated aspergillosis: data from three consecutive influenza seasons.
Topics: Adult; Aged; Aspergillosis; Bronchoalveolar Lavage Fluid; Case-Control Studies; Clinical Laboratory Techniques; Critical Illness; Female; Galactose; Humans; Influenza, Human; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Predictive Value of Tests; Retrospective Studies; ROC Curve; Seasons; Sensitivity and Specificity | 2021 |
Role of pre-transplant chest high-resolution computed tomography and serum galactomannan index in predicting post-transplant invasive pulmonary aspergillosis in allogeneic hematopoietic cell transplant recipients.
Topics: Adult; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Mannans; Prospective Studies; Retrospective Studies; Tomography, X-Ray Computed; Transplant Recipients | 2021 |
Diagnosis values of IL-6 and IL-8 levels in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in chronic obstructive pulmonary disease.
Topics: Bronchoalveolar Lavage Fluid; Galactose; Humans; Interleukin-6; Interleukin-8; Invasive Pulmonary Aspergillosis; Mannans; Pulmonary Disease, Chronic Obstructive; Sensitivity and Specificity | 2021 |
Performance of the sōna
Topics: Aspergillus; Bronchoalveolar Lavage Fluid; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Neoplasms; Sensitivity and Specificity | 2021 |
Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Fungal; Aspergillus; Automation, Laboratory; Bronchoalveolar Lavage Fluid; Diagnostic Tests, Routine; Female; Galactose; Humans; Immunoassay; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2021 |
Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, Fungal; Bronchoalveolar Lavage Fluid; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Sensitivity and Specificity; Serum; Young Adult | 2017 |
Effect of involved Aspergillus species on galactomannan in bronchoalveolar lavage of patients with invasive aspergillosis.
Topics: Adolescent; Adult; Aged; Aspergillus flavus; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Child; Diagnostic Tests, Routine; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Iran; Male; Mannans; Middle Aged; Prospective Studies; Sensitivity and Specificity; Young Adult | 2017 |
Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis.
Topics: Animals; Antifungal Agents; Combined Modality Therapy; Echinocandins; Female; Galactose; Glucans; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung; Mannans; Micafungin; Nitriles; Pyridines; Rabbits; Triazoles | 2017 |
Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis.
Topics: Antifungal Agents; Antigens, Bacterial; Aspergillus; Bronchoalveolar Lavage Fluid; Diagnostic Tests, Routine; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Republic of Korea; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Tertiary Care Centers | 2018 |
Topics: Aspergillus fumigatus; DNA, Fungal; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Genes, rRNA; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Polymerase Chain Reaction; Real-Time Polymerase Chain Reaction; Tunisia | 2017 |
Clinical evaluation of the newly formatted lateral-flow device for invasive pulmonary aspergillosis.
Topics: Bronchoalveolar Lavage Fluid; Case-Control Studies; Chromatography, Affinity; Female; Galactose; Humans; Intensive Care Units; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Point-of-Care Systems; Prospective Studies; Sensitivity and Specificity | 2018 |
Aspergillus galactomannan detection in exhaled breath condensate compared to bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in immunocompromised patients.
Topics: Aged; Aspergillus; Breath Tests; Bronchoalveolar Lavage Fluid; Case-Control Studies; Cell Wall; Cross-Sectional Studies; Exhalation; Female; Galactose; Hematologic Neoplasms; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lung Transplantation; Male; Mannans; Middle Aged; Prospective Studies | 2018 |
Aspergillus Galactomannan for Diagnosing Invasive Aspergillosis.
Topics: Aged; Aspergillus fumigatus; Biopsy; Bronchoalveolar Lavage Fluid; Galactose; Granulomatosis with Polyangiitis; Humans; Immunocompromised Host; Immunoenzyme Techniques; Invasive Pulmonary Aspergillosis; Male; Mannans; Sensitivity and Specificity | 2017 |
Outbreak of invasive aspergillosis in heart transplant recipients: The role of screening computed tomography scans in asymptomatic patients and universal antifungal prophylaxis.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Asymptomatic Diseases; Cohort Studies; Disease Outbreaks; Echinocandins; Female; Galactose; Heart Transplantation; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Mass Screening; Micafungin; Middle Aged; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Transplant Recipients; Voriconazole | 2018 |
Characteristics of culture-positive invasive pulmonary aspergillosis in patients with hematologic diseases: Comparison between Aspergillus fumigatus and non-fumigatus Aspergillus species.
Topics: Adult; Aged; Aspergillus; Aspergillus fumigatus; Female; Galactose; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Paranasal Sinuses; Retrospective Studies | 2017 |
Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients.
Topics: Bronchoalveolar Lavage Fluid; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Neutropenia; Retrospective Studies | 2017 |
Invasive Aspergillus Pseudomembranous and Obstructive Tracheo-bronchitis in an Immuno-competent Patient.
Topics: Airway Obstruction; Antifungal Agents; Aspergillus; Bronchitis; Bronchoscopy; Female; Galactose; Hemoptysis; Humans; Invasive Pulmonary Aspergillosis; Mannans; Sputum; Tracheitis; Treatment Outcome; Voriconazole; Young Adult | 2017 |
Role of bi-weekly serum galactomannan screening for the diagnosis of invasive aspergillosis in haematological cancer patients.
Topics: Adult; Aged; Aspergillus; Bronchoalveolar Lavage Fluid; Female; Galactose; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Neutropenia; Polymerase Chain Reaction; Prognosis; Retrospective Studies; Sensitivity and Specificity | 2018 |
Evaluation of Two Commercial Real-Time PCR Kits for Aspergillus DNA Detection in Bronchoalveolar Lavage Fluid in Patients with Invasive Pulmonary Aspergillosis.
Topics: Adult; Aged; Aged, 80 and over; Bronchoalveolar Lavage Fluid; DNA, Fungal; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction | 2018 |
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Bronchoalveolar Lavage; Disease Management; Early Diagnosis; Flucytosine; Galactose; Humans; Immunocompromised Host; Immunologic Tests; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Mannans; Microbial Sensitivity Tests; Myelodysplastic Syndromes; Nitriles; Pyridines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2018 |
A strategy for prevention of fungal infections in lung transplantation: Role of bronchoalveolar lavage fluid galactomannan and fungal culture.
Topics: Adult; Bronchoalveolar Lavage Fluid; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Lung Transplantation; Male; Mannans; Middle Aged; Postoperative Complications; Retrospective Studies | 2018 |
Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Fungal; Aspergillus fumigatus; beta-Glucans; Female; Galactose; Humans; Immunoglobulin A; Immunoglobulin G; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Predictive Value of Tests; Proteoglycans; Retrospective Studies; Sensitivity and Specificity; Serum; Young Adult | 2018 |
Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Critical Illness; Echinocandins; Extracorporeal Membrane Oxygenation; Female; Galactose; Humans; Immunocompromised Host; Influenza, Human; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Micafungin; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Voriconazole; Young Adult | 2018 |
Urine Antigen Detection as an Aid to Diagnose Invasive Aspergillosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antigens, Fungal; Child; Cohort Studies; Galactose; Humans; Immunoassay; Invasive Pulmonary Aspergillosis; Mannans; Middle Aged; Reagent Strips; Sensitivity and Specificity; Young Adult | 2018 |
A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model.
Topics: A549 Cells; Aspergillus fumigatus; Biomarkers; Computer Simulation; Dose-Response Relationship, Drug; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Microbial Sensitivity Tests; Monte Carlo Method; Regression Analysis; Voriconazole | 2018 |
Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-D-glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study.
Topics: Adult; Aged; Aged, 80 and over; Aspergillus; beta-Glucans; Bronchoalveolar Lavage Fluid; Critical Illness; Diagnostic Tests, Routine; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Pilot Projects; Polymerase Chain Reaction; Prospective Studies; Young Adult | 2018 |
Aspergillus terreus Causing Probable Invasive Aspergillosis in a Patient with Cystic Fibrosis.
Topics: Antifungal Agents; Aspergillus; Child; Cystic Fibrosis; Drug Monitoring; Galactose; Humans; India; Invasive Pulmonary Aspergillosis; Male; Mannans; Treatment Outcome; Voriconazole | 2019 |
Bronchoalveolar lavage Aspergillus Galactomannan lateral flow assay versus Aspergillus-specific lateral flow device test for diagnosis of invasive pulmonary Aspergillosis in patients with hematological malignancies.
Topics: Aspergillosis; Aspergillus; Bronchoalveolar Lavage; Cytokines; Galactose; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Mannans; Polymerase Chain Reaction | 2019 |
Liposomal amphotericin B pharmacokinetics in a patient treated with extracorporeal membrane oxygenation.
Topics: Adult; Amphotericin B; Antifungal Agents; Antigens, Fungal; Area Under Curve; Bronchoalveolar Lavage Fluid; Extracorporeal Membrane Oxygenation; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Liposomes; Mannans; Respiratory Distress Syndrome | 2019 |
Utility of serum galactomannan antigen testing combined with chest computed tomography for early diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies with febrile neutropenia after antifungal drug treatment.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillus; Early Diagnosis; Febrile Neutropenia; Female; Follow-Up Studies; Galactose; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2019 |
Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus-specific Lateral Flow Device test in bronchoalveolar lavage.
Topics: Adult; Aged; Aged, 80 and over; Bronchoalveolar Lavage Fluid; California; Female; Galactose; Hospitals, University; Humans; Immunoassay; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Point-of-Care Systems; Sensitivity and Specificity; Young Adult | 2019 |
Diagnosing Invasive Pulmonary Aspergillosis in Hematology Patients: a Retrospective Multicenter Evaluation of a Novel Lateral Flow Device.
Topics: Aged; Antigens, Fungal; Aspergillus; Belgium; Bronchoalveolar Lavage Fluid; Diagnostic Tests, Routine; Female; Galactose; Hematologic Diseases; Hematology; Humans; Immunoassay; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Netherlands; Retrospective Studies; Sensitivity and Specificity | 2019 |
Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan.
Topics: Adult; Aged; Aged, 80 and over; Aspergillus fumigatus; Blood Chemical Analysis; Bronchoalveolar Lavage Fluid; Female; Galactose; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Molecular Diagnostic Techniques; Real-Time Polymerase Chain Reaction; Retrospective Studies; Sensitivity and Specificity; Time Factors; Young Adult | 2019 |
[Diagnostic value of the combinations of bronchoalveolar lavage fluid galactomannan test and serum galactomannan test in invasive pulmonary aspergillosis].
Topics: Bronchoalveolar Lavage Fluid; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Sensitivity and Specificity | 2019 |
Detection of Invasive Aspergillosis in Critically Ill Patients with Influenza: The Role of Plasma Galactomannan.
Topics: Biomarkers; Critical Illness; Female; Galactose; Humans; Influenza, Human; Invasive Pulmonary Aspergillosis; Male; Mannans | 2019 |
Performance of the AsperGenius® PCR assay for detecting azole resistant Aspergillus fumigatus in BAL fluids from allogeneic HSCT recipients: A prospective cohort study from Essen, West Germany.
Topics: Adult; Aged; Antifungal Agents; Aspergillus fumigatus; Azoles; Bronchoalveolar Lavage Fluid; Colony Count, Microbial; Drug Resistance, Fungal; Female; Galactose; Germany; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Microbial Sensitivity Tests; Middle Aged; Molecular Diagnostic Techniques; Multiplex Polymerase Chain Reaction; Prospective Studies; Reagent Kits, Diagnostic; Sensitivity and Specificity; Transplant Recipients | 2020 |
Usefulness of ICU criteria for diagnosis of invasive pulmonary aspergillosis in nonhematologic critically ill patients.
Topics: Aged; Bronchoalveolar Lavage Fluid; Critical Illness; Female; Galactose; Humans; Immunosuppressive Agents; Intensive Care Units; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Organ Transplantation; Radiology; Retrospective Studies | 2020 |
The early diagnostic value of serum galactomannan antigen test combined with chest computed tomography for invasive pulmonary aspergillosis in pediatric patients after hematopoietic stem cell transplantation.
Topics: Adolescent; Aspergillus; Biomarkers; Case-Control Studies; Child; Child, Preschool; Early Diagnosis; Female; Follow-Up Studies; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Invasive Pulmonary Aspergillosis; Male; Mannans; Prognosis; Radiography, Thoracic; Retrospective Studies; Tomography, X-Ray Computed | 2019 |
Lateral flow assays for diagnosing invasive pulmonary aspergillosis in adult hematology patients: A comparative multicenter study.
Topics: Aged; Bronchoalveolar Lavage Fluid; Chromatography, Affinity; Female; Galactose; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Retrospective Studies; Sensitivity and Specificity | 2020 |
Gliotoxin and bis(methylthio)gliotoxin are not reliable as biomarkers of invasive aspergillosis.
Topics: Biomarkers; Bronchoalveolar Lavage Fluid; Diagnostic Tests, Routine; Galactose; Gliotoxin; Humans; Invasive Pulmonary Aspergillosis; Mannans; Prospective Studies; Serum | 2019 |
Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy.
Topics: Adolescent; Adult; Antifungal Agents; Austria; Chemoprevention; Clinical Laboratory Techniques; Female; Galactose; Hematologic Neoplasms; Humans; Immunoenzyme Techniques; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2013 |
Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis.
Topics: Antibodies, Monoclonal; Antigens, Fungal; Aspergillus; Biomarkers; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 28S; Sensitivity and Specificity | 2013 |
Utility of galactomannan antigen detection in bronchoalveolar lavage fluid in immunocompromised patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antigens, Fungal; beta-Lactams; Bronchoalveolar Lavage Fluid; Enzyme-Linked Immunosorbent Assay; False Positive Reactions; Female; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2013 |
Bronchoalveolar lavage fluid galactomannan detection for diagnosis of invasive pulmonary aspergillosis in chronic obstructive pulmonary disease.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Blood Chemical Analysis; Bronchoalveolar Lavage Fluid; Clinical Laboratory Techniques; Cohort Studies; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Lung; Male; Mannans; Middle Aged; Mycology; Predictive Value of Tests; Prospective Studies; Pulmonary Disease, Chronic Obstructive; ROC Curve; Sensitivity and Specificity | 2013 |
The serum galactomannan index predicts mortality in hematopoietic stem cell transplant recipients with invasive aspergillosis.
Topics: Adult; Aged; Bronchoalveolar Lavage Fluid; Cohort Studies; Female; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Kaplan-Meier Estimate; Male; Mannans; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult | 2013 |
Performance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model.
Topics: Adult; Aged; Antifungal Agents; Antigens, Fungal; Antineoplastic Agents; beta-Glucans; Biomarkers; Chemotherapy-Induced Febrile Neutropenia; DNA, Fungal; Early Diagnosis; Female; Fungal Polysaccharides; Galactose; Genes, Fungal; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Mannans; Markov Chains; Middle Aged; Models, Biological; Prospective Studies; Randomized Controlled Trials as Topic; Real-Time Polymerase Chain Reaction | 2013 |
Early diagnosis and treatment of invasive pulmonary aspergillosis in a patient with cystic fibrosis.
Topics: Antifungal Agents; beta-Glucans; Biomarkers; Bronchoalveolar Lavage; Child; Cystic Fibrosis; Early Diagnosis; Fatal Outcome; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Pyrimidines; Triazoles; Voriconazole | 2013 |
Prognostic value of serum galactomannan index in critically ill patients with chronic obstructive pulmonary disease at risk of invasive pulmonary aspergillosis.
Topics: Aged; Aged, 80 and over; Critical Illness; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive | 2014 |
Threshold of galactomannan antigenemia positivity for early diagnosis of invasive aspergillosis in neutropenic children.
Topics: Adolescent; Antigens, Fungal; Child; Child, Preschool; Early Diagnosis; Female; Galactose; Humans; Infant; Invasive Pulmonary Aspergillosis; Male; Mannans; Neutropenia; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity | 2016 |
What's new in invasive pulmonary aspergillosis in the critically ill.
Topics: Antifungal Agents; Antigens; Biomarkers; Critical Illness; Early Diagnosis; Galactose; Humans; Immunocompromised Host; Immunologic Techniques; Incidence; Invasive Pulmonary Aspergillosis; Mannans; Opportunistic Infections | 2014 |
Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
Topics: Adult; Aged; Antigens, Fungal; Aspergillus; Austria; Bronchoalveolar Lavage Fluid; Chromatography, Affinity; DNA, Fungal; Female; Galactose; Germany; Glucans; Hospitals, University; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Microbiological Techniques; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2014 |
Independent contribution of bronchoalveolar lavage and serum galactomannan in the diagnosis of invasive pulmonary aspergillosis.
Topics: Adolescent; Adult; Aged; Aspergillus; Bronchoalveolar Lavage Fluid; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Retrospective Studies; Transplantation; Young Adult | 2014 |
Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.
Topics: Anti-Bacterial Agents; Antigens, Fungal; beta-Glucans; beta-Lactams; False Positive Reactions; Galactose; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Mannans; Proteoglycans; Sensitivity and Specificity; Serum | 2014 |
Evaluation of galactomannan enzyme immunoassay and quantitative real-time PCR for the diagnosis of invasive pulmonary aspergillosis in a rat model.
Topics: Animals; Aspergillus fumigatus; Diagnostic Tests, Routine; Disease Models, Animal; Galactose; Immunoenzyme Techniques; Invasive Pulmonary Aspergillosis; Mannans; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; ROC Curve; Sensitivity and Specificity | 2014 |
Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, Fungal; Aspergillus; Bronchoalveolar Lavage Fluid; DNA, Fungal; Galactose; Hematologic Neoplasms; Humans; Immunoassay; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Polymerase Chain Reaction; Predictive Value of Tests; Sensitivity and Specificity; Young Adult | 2014 |
Aspergillus colonization in patients with bronchogenic carcinoma.
Topics: Antigens, Fungal; Areca; Aspergillus; Bronchoalveolar Lavage Fluid; Bronchoscopy; Carcinoma, Bronchogenic; Female; Galactose; Humans; India; Invasive Pulmonary Aspergillosis; Lung; Lung Neoplasms; Male; Mannans; Mastication; Membrane Glycoproteins; Middle Aged; Prevalence; Risk Factors; Smoking | 2014 |
The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections.
Topics: beta-Glucans; Bronchoalveolar Lavage Fluid; Female; Fusariosis; Galactose; Humans; Invasive Pulmonary Aspergillosis; Lung Diseases, Fungal; Male; Mannans; Mucormycosis; Paecilomyces; Pneumonia, Pneumocystis; Reproducibility of Results; Retrospective Studies; Scopulariopsis; Sensitivity and Specificity | 2014 |
Impact and cost of the serum galactomannan assay at a tertiary care facility.
Topics: Adult; Antifungal Agents; Antigens, Fungal; Child; Cost-Benefit Analysis; Electronic Health Records; Galactose; Health Care Costs; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Mannans; Retrospective Studies; Tertiary Care Centers; Treatment Outcome | 2014 |
The effect of sample storage on the performance and reproducibility of the galactomannan EIA test.
Topics: Antigens, Fungal; Blood Chemical Analysis; Diagnostic Tests, Routine; Galactose; Humans; Immunoenzyme Techniques; Invasive Pulmonary Aspergillosis; Mannans; Preservation, Biological; Reproducibility of Results; Specimen Handling; Temperature; Time Factors | 2014 |
Development of a novel inhalational model of invasive pulmonary aspergillosis in rats and comparative evaluation of three biomarkers for its diagnosis.
Topics: Animals; Aspergillus fumigatus; beta-Glucans; Biological Assay; Biomarkers; Bronchoalveolar Lavage; Disease Models, Animal; Female; Galactose; Immunocompromised Host; Inhalation; Invasive Pulmonary Aspergillosis; Lung; Mannans; Polymerase Chain Reaction; Rats; Rats, Wistar | 2014 |
Predictors of mortality in non-neutropenic patients with invasive pulmonary aspergillosis: does galactomannan have a role?
Topics: Adult; Aged; Aged, 80 and over; Bronchoalveolar Lavage Fluid; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Predictive Value of Tests; Prognosis; Retrospective Studies; ROC Curve | 2014 |
Galactomannan in bronchoalveolar lavage for diagnosing invasive fungal disease.
Topics: Adult; Antifungal Agents; Area Under Curve; Biomarkers; Bronchoalveolar Lavage Fluid; Bronchoscopy; Chemoprevention; Female; Galactose; Hematologic Neoplasms; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Logistic Models; Male; Mannans; Middle Aged; Prospective Studies; Sensitivity and Specificity; Statistics, Nonparametric; Switzerland | 2014 |
Performance of MycAssay Aspergillus DNA real-time PCR assay compared with the galactomannan detection assay for the diagnosis of invasive aspergillosis from serum samples.
Topics: Adult; Aged; Aged, 80 and over; Aspergillus; DNA, Fungal; Female; Galactose; Hematologic Neoplasms; Humans; Immunoenzyme Techniques; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Real-Time Polymerase Chain Reaction; Retrospective Studies; Sensitivity and Specificity; Serum | 2014 |
As galactomannan disappoints, our quest for a feasible diagnostic standard for invasive aspergillosis continues.
Topics: Bronchoalveolar Lavage Fluid; Female; Galactose; Hematologic Neoplasms; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans | 2014 |
In vitro and in vivo antifungal activity of Cassia surattensis flower against Aspergillus niger.
Topics: Animal Structures; Animals; Antifungal Agents; Aspergillus niger; Cassia; Colony Count, Microbial; Disease Models, Animal; Flowers; Galactose; Invasive Pulmonary Aspergillosis; Mannans; Mice, Inbred BALB C; Microbial Sensitivity Tests; Plant Extracts; Treatment Outcome | 2014 |
Immune reconstitution inflammatory syndrome in neutropenic patients with invasive pulmonary aspergillosis.
Topics: Antifungal Agents; Female; Galactose; Humans; Immune Reconstitution Inflammatory Syndrome; Invasive Pulmonary Aspergillosis; Lung; Male; Mannans; Middle Aged; Neutropenia; Republic of Korea; Retrospective Studies; Voriconazole | 2015 |
The diagnosis of invasive and noninvasive pulmonary aspergillosis by serum and bronchoalveolar lavage fluid galactomannan assay.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bronchoalveolar Lavage; Female; Galactose; Humans; Immunoenzyme Techniques; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Retrospective Studies | 2015 |
Potential of polymerase chain reaction and galactomannan for the diagnosis of invasive aspergillosis in patients with febrile neutropenia.
Topics: Adult; Aspergillus; DNA, Fungal; Febrile Neutropenia; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Molecular Diagnostic Techniques; Polymerase Chain Reaction; Sensitivity and Specificity; Serologic Tests; Young Adult | 2015 |
Improved Standardization of the Bio-Rad Platelia Aspergillus Galactomannan Antigen Sandwich Enzyme Immunoassay Using the DS2 (Dynex) Enzyme-Linked Immunosorbent Assay (ELISA) Processing System.
Topics: Antigens, Fungal; Aspergillus; Automation, Laboratory; Diagnostic Tests, Routine; Galactose; Humans; Immunoenzyme Techniques; Invasive Pulmonary Aspergillosis; Mannans; Reference Standards; Reproducibility of Results | 2015 |
Invasive pulmonary aspergillosis in heart transplant recipients.
Topics: Adult; Antifungal Agents; Aspergillus; Biomarkers; Bronchoalveolar Lavage Fluid; Female; Galactose; Heart Transplantation; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Lung; Male; Mannans; Medical Records; Middle Aged; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Turkey | 2015 |
Performance of lateral flow device and galactomannan for the detection of Aspergillus species in bronchoalveolar fluid of patients at risk for invasive pulmonary aspergillosis.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Fungal; Aspergillus; Bronchoalveolar Lavage Fluid; Chromatography, Affinity; False Positive Reactions; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Prospective Studies; Sensitivity and Specificity | 2015 |
Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.
Topics: Aged; Aspergillus; Austria; Biomarkers; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Female; Galactose; Hematologic Neoplasms; Humans; Immunologic Tests; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Point-of-Care Testing; Prospective Studies; Sensitivity and Specificity | 2015 |
Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis.
Topics: Adult; Aged; Antifungal Agents; Aspergillus; beta-Glucans; Biomarkers; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Prognosis; Prospective Studies; Survival Analysis; Treatment Outcome | 2015 |
Combining standard clinical methods with PCR showed improved diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies and prolonged neutropenia.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Antigens, Fungal; Aspergillus fumigatus; Case-Control Studies; DNA, Fungal; Female; Galactose; Hematologic Neoplasms; Humans; Immunoassay; Invasive Pulmonary Aspergillosis; Lung; Male; Mannans; Middle Aged; Neutropenia; Pilot Projects; Polymerase Chain Reaction; Prospective Studies; Tomography, X-Ray Computed; Young Adult | 2015 |
Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1→3)-β-D-glucan in experimental invasive pulmonary aspergillosis.
Topics: Animals; Antifungal Agents; beta-Glucans; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Female; Galactose; Host-Pathogen Interactions; Invasive Pulmonary Aspergillosis; Lung; Mannans; Proteoglycans; Rabbits | 2015 |
Combining Aspergillus mitochondrial and ribosomal QPCR, in addition to galactomannan assay, for early diagnosis of invasive aspergillosis in hematology patients.
Topics: Aspergillus; Early Diagnosis; France; Galactose; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Mannans; Prospective Studies; Real-Time Polymerase Chain Reaction; Serum | 2015 |
Serum galactomannan index for early prediction of mortality in immunocompromised children with invasive pulmonary aspergillosis.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Galactose; Humans; Immunocompromised Host; Infant; Invasive Pulmonary Aspergillosis; Male; Mannans; Medical Records; Republic of Korea; Retrospective Studies; Sensitivity and Specificity | 2015 |
Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antigens, Viral; Aspergillus; Austria; Bronchoalveolar Lavage Fluid; Chromatography, Affinity; False Negative Reactions; Female; Galactose; Germany; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2015 |
Bronchoalveolar galactomannan in invasive pulmonary aspergillosis: a prospective study in pediatric patients.
Topics: Adolescent; Bronchoalveolar Lavage Fluid; Case-Control Studies; Child; Child, Preschool; Female; Galactose; Humans; Immunocompromised Host; Infant; Invasive Pulmonary Aspergillosis; Male; Mannans; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity | 2015 |
Timing of broncho-alveolar lavage for galactomannan testing in hematological oncology patients.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Bronchoscopy; Female; Galactose; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Tomography, X-Ray Computed | 2017 |
Serum galactomannan levels in the diagnosis of invasive aspergillosis.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Opportunistic Infections; Predictive Value of Tests; Reproducibility of Results; Time Factors | 2015 |
Galactomannan antigen detection using bronchial wash and bronchoalveolar lavage in patients with hematologic malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Fungal; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Diagnostic Tests, Routine; Female; Galactose; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Retrospective Studies; Young Adult | 2015 |
Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.
Topics: Adult; Aged; Antigens, Fungal; Aspergillus; Biomarkers; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Early Diagnosis; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2016 |
Multiple myeloma as a major cause of false-positive galactomannan tests in adult patients with cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; False Positive Reactions; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Multiple Myeloma; Young Adult | 2016 |
[Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
Topics: Adult; Aged; Aged, 80 and over; Aspergillus; Bronchoalveolar Lavage Fluid; Confidence Intervals; DNA, Fungal; Female; Galactose; Humans; Immunoenzyme Techniques; Intensive Care Units; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Polymerase Chain Reaction; Risk Factors; ROC Curve; Sensitivity and Specificity | 2015 |
Clinical validity of bis(methylthio)gliotoxin for the diagnosis of invasive aspergillosis.
Topics: Aged; Aged, 80 and over; Biomarkers; Female; Galactose; Gliotoxin; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity | 2016 |
Comparison of Nonculture Blood-Based Tests for Diagnosing Invasive Aspergillosis in an Animal Model.
Topics: Animals; beta-Glucans; Blood; Diagnostic Tests, Routine; Disease Models, Animal; Galactose; Guinea Pigs; Invasive Pulmonary Aspergillosis; Male; Mannans; Molecular Diagnostic Techniques; Polymerase Chain Reaction; Proteoglycans; Sensitivity and Specificity; Time Factors | 2016 |
Pharmacokinetics and Concentration-Dependent Efficacy of Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Female; Galactose; Invasive Pulmonary Aspergillosis; Mannans; Nitriles; Pyridines; Rabbits; Triazoles | 2016 |
Aspergillus PCR in serum for the diagnosis, follow-up and prognosis of invasive aspergillosis in neutropenic and nonneutropenic patients.
Topics: Adult; Aged; Aged, 80 and over; Aspergillus; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Molecular Diagnostic Techniques; Neoplasms; Neutropenia; Polymerase Chain Reaction; Predictive Value of Tests; Prognosis; Retrospective Studies; Sensitivity and Specificity; Serum; Young Adult | 2016 |
Galactomannan Testing and the Incidence of Invasive Pulmonary Aspergillosis: A 10-Year Nationwide Population-Based Study in Taiwan.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Diagnostic Tests, Routine; Female; Galactose; Humans; Incidence; Infant; Infant, Newborn; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Sensitivity and Specificity; Taiwan; Young Adult | 2016 |
Longitudinal, in vivo assessment of invasive pulmonary aspergillosis in mice by computed tomography and magnetic resonance imaging.
Topics: Animals; Aspergillus fumigatus; Colony Count, Microbial; Disease Models, Animal; Disease Progression; Galactose; Invasive Pulmonary Aspergillosis; Longitudinal Studies; Lung; Magnetic Resonance Imaging; Male; Mannans; Mice; Mice, Inbred BALB C; Spores, Fungal; Tomography, X-Ray Computed | 2016 |
Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients.
Topics: Adult; Bronchoalveolar Lavage Fluid; Female; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Neutropenia; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Sensitivity and Specificity; Spain; Young Adult | 2016 |
A 10-year study reveals clinical and laboratory evidence for the 'semi-invasive' properties of chronic pulmonary aspergillosis.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Fungal; Aspergillus; Child; Chronic Disease; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Microbiological Techniques; Middle Aged; Prognosis; Pulmonary Aspergillosis; Survival Rate; Time Factors; Young Adult | 2016 |
Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; beta-Glucans; Critical Illness; Diagnostic Tests, Routine; Early Diagnosis; Female; Galactose; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Proteoglycans; Sensitivity and Specificity; Serum; Shock, Septic; Young Adult | 2016 |
Quantitative Real-Time PCR and Platelia Galactomannan Assay for the Diagnosis of Invasive Pulmonary Aspergillosis: Bronchoalveolar Lavage Fluid Performs Better Than Serum in Non-neutropaenic Patients.
Topics: Bronchoalveolar Lavage Fluid; Diagnostic Tests, Routine; DNA, Fungal; Galactose; Humans; Immunoassay; Invasive Pulmonary Aspergillosis; Mannans; Real-Time Polymerase Chain Reaction; Retrospective Studies; Sensitivity and Specificity; Serum | 2016 |
Blood Aspergillus RNA is a promising alternative biomarker for invasive aspergillosis.
Topics: Antifungal Agents; Aspergillus; beta-Glucans; Biomarkers; Drug Monitoring; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Nucleic Acid Amplification Techniques; Prognosis; Prospective Studies; Proteoglycans; RNA, Fungal; Time Factors; Treatment Outcome | 2016 |
Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; APACHE; Aspergillus; Autoimmune Diseases; beta-Glucans; Biomarkers; Bronchoalveolar Lavage Fluid; Critical Illness; Early Diagnosis; Female; Galactose; Graft Rejection; Humans; Immunocompromised Host; Immunosuppressive Agents; Intensive Care Units; Invasive Pulmonary Aspergillosis; Length of Stay; Male; Mannans; Middle Aged; Mortality; Neoplasms; Neutropenia; Organ Dysfunction Scores; Organ Transplantation; Respiration, Artificial; Respiratory Insufficiency; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2016 |
Bronchoalveolar lavage fluid galactomannan as a diagnostic biomarker for IPA: still a long way to go.
Topics: Biomarkers; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Sensitivity and Specificity | 2016 |
Prospective Biomarker Screening for Diagnosis of Invasive Aspergillosis in High-Risk Pediatric Patients.
Topics: Adolescent; Biomarkers; Child; Child, Preschool; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Polymerase Chain Reaction; Predictive Value of Tests; Retrospective Studies; RNA, Ribosomal, 5.8S; Sensitivity and Specificity; Young Adult | 2017 |
Utility of the serum galactomannan assay for the diagnosis of invasive aspergillosis in children with acute lymphoblastic leukemia.
Topics: Adolescent; Child; Child, Preschool; Female; Galactose; Humans; Infant; Invasive Pulmonary Aspergillosis; Male; Mannans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Sensitivity and Specificity | 2017 |
Diagnosis of Invasive Pulmonary Aspergillosis.
Topics: Antigens, Fungal; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Poland; Retrospective Studies | 2017 |
The current management landscape: aspergillosis.
Topics: Aspergillus; beta-Glucans; Biomarkers; Bronchoalveolar Lavage Fluid; DNA, Fungal; Galactose; Humans; Immunologic Deficiency Syndromes; Invasive Pulmonary Aspergillosis; Mannans; Polymerase Chain Reaction | 2016 |
Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia.
Topics: Anti-Bacterial Agents; Antigens, Fungal; False Positive Reactions; Febrile Neutropenia; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Microbiological Techniques; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2017 |
Serial assessment of pulmonary lesion volume by computed tomography allows survival prediction in invasive pulmonary aspergillosis.
Topics: Adult; Aged; Disease Progression; Female; Galactose; Humans; Image Interpretation, Computer-Assisted; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Pneumonia; Predictive Value of Tests; Survival Analysis; Tomography, X-Ray Computed | 2017 |
[Evaluation of the galactomannan assay for the diagnosis of invasive aspergillosis in patients].
Topics: Adult; Aged; Aged, 80 and over; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Predictive Value of Tests; Sensitivity and Specificity; Young Adult | 2008 |
The role of bronchoalveolar lavage galactomannan in the diagnosis of pediatric invasive aspergillosis.
Topics: Biomarkers; Bronchoalveolar Lavage Fluid; Child; Female; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Statistics, Nonparametric | 2009 |
Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Drug Therapy, Combination; Echinocandins; Female; Galactose; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Kidney; Lipopeptides; Lung; Mannans; Micafungin; Mice; Mice, Inbred ICR; Spleen; Survival Analysis | 2009 |
[Value of serum galactomannan assay in the diagnosis of pediatric invasive pulmonary aspergillosis].
Topics: Adolescent; Child; Child, Preschool; Female; Galactose; Humans; Infant; Invasive Pulmonary Aspergillosis; Male; Mannans; Serologic Tests | 2009 |
[The role of galactomannan detection in the diagnosis of invasive pulmonary aspergillosis in critically ill patients].
Topics: Adult; Aged; Aged, 80 and over; Critical Illness; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Prospective Studies; Sensitivity and Specificity | 2009 |
Comparison of lateral flow technology and galactomannan and (1->3)-beta-D-glucan assays for detection of invasive pulmonary aspergillosis.
Topics: Animals; Antigens, Fungal; Aspergillus; beta-Glucans; Biomarkers; Chromatography, Liquid; Galactose; Guinea Pigs; Immunoassay; Invasive Pulmonary Aspergillosis; Male; Mannans; Point-of-Care Systems; Proteoglycans; Sensitivity and Specificity | 2009 |
Detection of sputum Aspergillus galactomannan for diagnosis of invasive pulmonary aspergillosis in haematological patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspergillus; Bronchoalveolar Lavage Fluid; Child; Early Diagnosis; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Hematologic Diseases; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Risk Factors; Sensitivity and Specificity; Sputum; Young Adult | 2009 |
Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases.
Topics: Bronchoalveolar Lavage Fluid; Case-Control Studies; Galactose; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Mannans; Middle Aged; Retrospective Studies; Sensitivity and Specificity | 2009 |
[Diagnosis of invasive pulmonary aspergillosis: value of bronchoalveolar lavage galactomannan for immunocompromised patients].
Topics: Aspergillus; Bronchoalveolar Lavage Fluid; Enzyme-Linked Immunosorbent Assay; Galactose; Hematologic Neoplasms; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Mannans; Mycology; Neutropenia; Postoperative Complications; Retrospective Studies; Sensitivity and Specificity | 2010 |
Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients.
Topics: Adolescent; Adult; Aged; Bronchoalveolar Lavage Fluid; Case-Control Studies; Child; Female; Galactose; Hematologic Neoplasms; Humans; Immunoassay; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Prospective Studies; Sensitivity and Specificity; Young Adult | 2010 |
Bronchoalveolar lavage fluid galactomannan for diagnosis of invasive pulmonary aspergillosis.
Topics: Antigens, Fungal; Bronchoalveolar Lavage Fluid; False Negative Reactions; False Positive Reactions; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans | 2010 |
Galactomannan detection and diagnosis of invasive aspergillosis.
Topics: Antigens, Fungal; Bronchoalveolar Lavage Fluid; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Mycological Typing Techniques; Sensitivity and Specificity | 2010 |
Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Female; Follow-Up Studies; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lung Diseases, Fungal; Male; Mannans; Middle Aged; Prospective Studies; Risk; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Young Adult | 2010 |
Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Biomarkers; Bronchoalveolar Lavage Fluid; Bronchoscopy; Chi-Square Distribution; Child; False Positive Reactions; Female; Galactose; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Lung Transplantation; Male; Mannans; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Reagent Kits, Diagnostic; ROC Curve; Sensitivity and Specificity; Treatment Outcome; Young Adult | 2010 |
The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3) β-d-glucan and consequences of delayed antifungal therapy.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; beta-Glucans; Deoxycholic Acid; Drug Combinations; Galactose; Invasive Pulmonary Aspergillosis; Mannans; Proteoglycans; Rabbits | 2010 |
A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan
Topics: Adult; Aged; beta-Glucans; Bronchoalveolar Lavage Fluid; Critical Care; Critical Illness; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Prospective Studies; Proteoglycans; ROC Curve; Serum | 2011 |
Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, Fungal; Aspergillus; Bronchoalveolar Lavage Fluid; Cohort Studies; False Positive Reactions; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2010 |
Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies.
Topics: Antigens, Fungal; Aspergillus; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Bronchoscopy; Canada; Cohort Studies; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunoenzyme Techniques; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Mycological Typing Techniques; Opportunistic Infections; Predictive Value of Tests; Prognosis; Retrospective Studies; Sensitivity and Specificity | 2010 |
Value of consecutive galactomannan determinations for the diagnosis and prognosis of invasive pulmonary aspergillosis in critically ill chronic obstructive pulmonary disease.
Topics: Aspergillus; Critical Illness; Galactose; Humans; Intensive Care Units; Invasive Pulmonary Aspergillosis; Mannans; Opportunistic Infections; Prognosis; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Sensitivity and Specificity; Sputum | 2011 |
[Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
Topics: Animals; Antigens, Fungal; Aspergillus fumigatus; beta-Glucans; Bronchoalveolar Lavage Fluid; Disease Models, Animal; DNA, Fungal; Enzyme-Linked Immunosorbent Assay; Female; Fluorouracil; Galactose; Immunosuppression Therapy; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Lung; Mannans; Neutropenia; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity | 2010 |
Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Biomarkers; Biopsy; Bronchoalveolar Lavage Fluid; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Postoperative Complications; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Triazoles; Voriconazole | 2011 |
Comparison of PCR-ELISA and Real-Time PCR for invasive aspergillosis diagnosis in patients with hematological malignancies.
Topics: Adolescent; Adult; Aged; Antigens, Fungal; Aspergillus; Bronchoalveolar Lavage Fluid; Child; Child, Preschool; Cohort Studies; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Hematologic Neoplasms; Humans; Infant; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Sensitivity and Specificity; Serum; Young Adult | 2011 |
Ribosomal and mitochondrial DNA target for real-time PCR diagnosis of invasive aspergillosis.
Topics: Adolescent; Adult; Aged; Aspergillus; Child; DNA, Fungal; DNA, Mitochondrial; DNA, Ribosomal; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Mycology; Polymerase Chain Reaction; Sensitivity and Specificity; Young Adult | 2011 |
[Association between genetic polymorphism in the promotor region of CD209 and propensity to develop invasive pulmonary aspergillosis].
Topics: Antigens, Fungal; Case-Control Studies; Cell Adhesion Molecules; Galactose; Gene Frequency; Genetic Predisposition to Disease; Hematologic Neoplasms; Humans; Immunity, Innate; Invasive Pulmonary Aspergillosis; Lectins, C-Type; Mannans; Phenotype; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Receptors, Cell Surface; Risk Assessment; Risk Factors | 2010 |
Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients.
Topics: Adult; Aged; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Clinical Laboratory Techniques; DNA, Fungal; Female; Galactose; Humans; Immunoenzyme Techniques; Invasive Pulmonary Aspergillosis; Lung Transplantation; Male; Mannans; Middle Aged; Mycology; Polymerase Chain Reaction; Sensitivity and Specificity; Transplantation | 2011 |
Serum galactomannan strongly correlates with outcome of invasive aspergillosis in acute leukaemia patients.
Topics: Adolescent; Adult; Aged; Clinical Laboratory Techniques; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Leukemia; Male; Mannans; Middle Aged; Retrospective Studies; Serum; Survival Analysis; Treatment Outcome; Young Adult | 2011 |
Resolution of galactomannan antigenemia in a patient receiving oral voriconazole for chronic necrotizing pulmonary aspergillosis.
Topics: Antifungal Agents; Antigens, Fungal; Drug Monitoring; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2011 |
Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Drug Therapy, Combination; Female; France; Galactose; Hospitals; Humans; Immunocompromised Host; Incidence; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Prospective Studies; Risk Factors; Seasons; Young Adult | 2011 |
Usefulness of serial determination of Aspergillus galactomannan in the diagnosis and management of invasive aspergillosis in an AIDS patient with non-Hodgkin lymphoma.
Topics: Acquired Immunodeficiency Syndrome; Antigens, Fungal; Aspergillus; Bronchoalveolar Lavage Fluid; Galactose; Humans; Invasive Pulmonary Aspergillosis; Lymphoma, Non-Hodgkin; Male; Mannans; Middle Aged | 2011 |
Clinical utility and development of biomarkers in invasive aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Biomarkers; Disease Models, Animal; DNA, Fungal; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Predictive Value of Tests; Prognosis; Severity of Illness Index; Virulence Factors | 2011 |
Earlier response assessment in invasive aspergillosis based on the kinetics of serum Aspergillus galactomannan: proposal for a new definition.
Topics: Adult; Aged; Aged, 80 and over; Drug Monitoring; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Serum; Time Factors | 2011 |
Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Comorbidity; Early Diagnosis; Female; Galactose; Hospital Units; Hospitals, University; Humans; Invasive Pulmonary Aspergillosis; Italy; Leukocyte Count; Male; Mannans; Middle Aged; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2011 |
Twenty-nine cases of invasive aspergillosis in neutropenic patients.
Topics: Adolescent; Adult; Aged; Antigens, Fungal; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus; Brain Abscess; Child; Child, Preschool; Dermatomycoses; Enzyme-Linked Immunosorbent Assay; Female; Fungemia; Galactose; Hematologic Neoplasms; Humans; Induction Chemotherapy; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Neuroaspergillosis; Neutropenia; Sinusitis; Survival Rate; Tomography, X-Ray Computed; Tunisia; Young Adult | 2011 |
Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillus; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cohort Studies; Female; Galactose; Hematologic Diseases; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Neutropenia; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2011 |
Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Biomarkers; Caspofungin; Disease Models, Animal; DNA, Fungal; Early Diagnosis; Echinocandins; Galactose; Immunoenzyme Techniques; Invasive Pulmonary Aspergillosis; Lipopeptides; Mannans; Microbiological Techniques; Mycological Typing Techniques; Predictive Value of Tests; Rats; Real-Time Polymerase Chain Reaction; Time Factors; Triazoles | 2012 |
Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Bronchoalveolar Lavage Fluid; Child; Cohort Studies; Female; Galactose; Hematologic Neoplasms; Humans; Immunocompromised Host; Infant; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Neutropenia; Prognosis; Sensitivity and Specificity | 2012 |
Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Antigens, Fungal; Biomarkers; Child; Female; Galactose; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Longitudinal Studies; Male; Mannans; Middle Aged; Prognosis; Prospective Studies; Steroids; Survival Analysis; Treatment Outcome; Young Adult | 2012 |
Detection and measurement of fungal burden in a guinea pig model of invasive pulmonary aspergillosis by novel quantitative nested real-time PCR compared with galactomannan and (1,3)-β-D-glucan detection.
Topics: Animals; Aspergillus fumigatus; beta-Glucans; Bronchoalveolar Lavage Fluid; Colony Count, Microbial; Disease Models, Animal; DNA, Fungal; DNA, Ribosomal Spacer; Galactose; Guinea Pigs; Invasive Pulmonary Aspergillosis; Lung; Male; Mannans; Mycology; Polymerase Chain Reaction; Proteoglycans; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity | 2012 |
Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bronchoalveolar Lavage Fluid; Female; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Retrospective Studies; ROC Curve; Young Adult | 2012 |
The performance of real-time PCR, galactomannan, and fungal culture in the diagnosis of invasive aspergillosis in ventilated patients with chronic obstructive pulmonary disease (COPD).
Topics: Aged; Aged, 80 and over; Aspergillus fumigatus; Cohort Studies; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Microbiological Techniques; Middle Aged; Mycology; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Real-Time Polymerase Chain Reaction | 2012 |
Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients.
Topics: Adolescent; Aspergillus; beta-Glucans; Child; Child, Preschool; Clinical Laboratory Techniques; Female; Galactose; Humans; Immunoenzyme Techniques; Infant; Invasive Pulmonary Aspergillosis; Male; Mannans; Polymerase Chain Reaction; Proteoglycans; Reagent Kits, Diagnostic | 2012 |
Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis.
Topics: Biomarkers; Drug Monitoring; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Prognosis; ROC Curve; Serum; Survival Analysis; Time Factors; Treatment Outcome | 2012 |
Comparison of serum and bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis in solid-organ transplant recipients.
Topics: Adult; Antifungal Agents; Biomarkers; Bronchoalveolar Lavage Fluid; Caspofungin; Drug Therapy, Combination; Echinocandins; Galactose; Heart Transplantation; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung Transplantation; Male; Mannans; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Transplantation; Triazoles; Voriconazole | 2012 |
Pharmacodynamics of voriconazole in a dynamic in vitro model of invasive pulmonary aspergillosis: implications for in vitro susceptibility breakpoints.
Topics: Antifungal Agents; Aspergillus fumigatus; Bioreactors; Cell Culture Techniques; Cells, Cultured; Chromatography, High Pressure Liquid; Computer Simulation; Decision Support Techniques; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Fungal; Endothelial Cells; Epithelial Cells; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Microbial Sensitivity Tests; Models, Biological; Pulmonary Artery; Pyrimidines; Respiratory Mucosa; Triazoles; Voriconazole | 2012 |
Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study.
Topics: Aged; Aged, 80 and over; APACHE; Biomarkers; Bronchoalveolar Lavage Fluid; Bronchoscopy; Critical Illness; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Hospital Mortality; Humans; Intensive Care Units; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Mycology; Predictive Value of Tests; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Sensitivity and Specificity | 2012 |
Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan.
Topics: Adolescent; Aspergillus; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Bronchoscopy; Child; Child, Preschool; Diagnosis, Differential; Early Diagnosis; Female; Follow-Up Studies; Galactose; Humans; Infant; Invasive Pulmonary Aspergillosis; Male; Mannans; Reproducibility of Results; Retrospective Studies | 2013 |
Interlaboratory and interstudy reproducibility of a novel lateral-flow device and influence of antifungal therapy on detection of invasive pulmonary aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillus; Bronchoalveolar Lavage Fluid; Colony Count, Microbial; Disease Models, Animal; Galactose; Glucans; Guinea Pigs; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Point-of-Care Systems; Reproducibility of Results; Time Factors | 2013 |
[The importance of bronchoalveolar lavage sample for galactomannan, 1,3-ß-d-glucan and PCR tests].
Topics: Antifungal Agents; beta-Glucans; Bronchoalveolar Lavage Fluid; Bronchoscopy; Child; Cystic Fibrosis; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lymphoma, Large B-Cell, Diffuse; Male; Mannans; Pyrimidines; Real-Time Polymerase Chain Reaction; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2012 |
Invasive pulmonary aspergillosis due to Emericella nidulans var. echinulata, successfully cured by voriconazole and micafungin.
Topics: Aged; Antifungal Agents; DNA, Fungal; Echinocandins; Emericella; Exudates and Transudates; Galactose; Glucocorticoids; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Micafungin; Microscopy; Molecular Sequence Data; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Serum galactomannan assay for the diagnosis of invasive aspergillosis in children with haematological malignancies.
Topics: Adolescent; Child; Child, Preschool; Female; Fungemia; Galactose; Hematologic Neoplasms; Humans; Infant; Invasive Pulmonary Aspergillosis; Male; Mannans; Predictive Value of Tests; Sensitivity and Specificity; Serum | 2013 |